- Home
- MNY vs BOLD Comparison
MNY vs BOLD Comparison
Compare MNY & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- BOLD
- Stock Information
- Founded
- MNY 2014
- BOLD 2018
- Country
- MNY Singapore
- BOLD United States
- Employees
- MNY N/A
- BOLD N/A
- Industry
- MNY
- BOLD
- Sector
- MNY
- BOLD
- Exchange
- MNY Nasdaq
- BOLD Nasdaq
- Market Cap
- MNY 43.9M
- BOLD 24.4M
- IPO Year
- MNY N/A
- BOLD 2024
- Fundamental
- Price
- MNY $1.77
- BOLD $1.19
- Analyst Decision
- MNY Strong Buy
- BOLD Buy
- Analyst Count
- MNY 1
- BOLD 3
- Target Price
- MNY $4.00
- BOLD $4.00
- AVG Volume (30 Days)
- MNY 684.9K
- BOLD 105.5K
- Earning Date
- MNY 09-18-2025
- BOLD 08-11-2025
- Dividend Yield
- MNY N/A
- BOLD N/A
- EPS Growth
- MNY N/A
- BOLD N/A
- EPS
- MNY N/A
- BOLD N/A
- Revenue
- MNY $71,649,746.00
- BOLD N/A
- Revenue This Year
- MNY $16.97
- BOLD N/A
- Revenue Next Year
- MNY $19.35
- BOLD N/A
- P/E Ratio
- MNY N/A
- BOLD N/A
- Revenue Growth
- MNY N/A
- BOLD N/A
- 52 Week Low
- MNY $0.55
- BOLD $1.00
- 52 Week High
- MNY $2.15
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- MNY 64.72
- BOLD N/A
- Support Level
- MNY $1.88
- BOLD N/A
- Resistance Level
- MNY $2.13
- BOLD N/A
- Average True Range (ATR)
- MNY 0.26
- BOLD 0.00
- MACD
- MNY 0.05
- BOLD 0.00
- Stochastic Oscillator
- MNY 66.67
- BOLD 0.00
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.